ERF — Eurofins Scientific SE Income Statement
0.000.00%
Last trade - 00:00
- €11.48bn
- €14.25bn
- €6.51bn
- 86
- 27
- 96
- 82
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,563 | 5,439 | 6,718 | 6,712 | 6,515 |
Cost of Revenue | |||||
Gross Profit | 931 | 1,413 | 1,902 | 1,513 | 1,364 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,989 | 4,415 | 5,245 | 5,675 | 5,673 |
Operating Profit | 574 | 1,024 | 1,473 | 1,037 | 842 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 477 | 920 | 1,369 | 904 | 736 |
Provision for Income Taxes | |||||
Net Income After Taxes | 360 | 707 | 1,043 | 683 | 568 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 195 | 540 | 783 | 610 | 310 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 146 | 505 | 749 | 581 | 257 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.67 | 3.43 | 5.03 | 3.51 | 2.91 |
Dividends per Share |